A global biotech wanted to understand the pan-omics (e.g. proteomics) digital health landscape and ecosystems within two key regional ecosystems
Using our proven Scouting solution, we worked alongside our client to ascertain and prioritise personal health ventures operating in the two target therapeutic areas across three regions. Leveraging our unique analytics, including our HealthTech Alpha score and our market insights, we identified a final selection of 10 ventures with optimal fit to our client’s criteria
| Number of countries | 5 |
| Number of Key TAs analysed | N/A |
| Number of ventures screened | 264 |
| Number of ventures shortlisted | 63 |
Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth
